When can low-dose aspirin (81 mg) be restarted after surgery?

When to Resume Aspirin After Surgery

Aspirin should be resumed as early as possible after surgery—ideally on the same day if hemostasis is adequate, or within 24 hours for most procedures, based on the individual bleeding risk assessment. 1

Timing Based on Clinical Context

Standard Surgical Procedures (No Coronary Stents)

For patients on aspirin monotherapy without recent stent placement:

• Same-day resumption is preferred when postoperative bleeding risk is acceptable 1
• Within 24 hours is reasonable for most low-to-moderate bleeding risk procedures 2, 3
• 24-72 hours delay may be appropriate for high-bleeding-risk procedures 2

The French Working Group on Perioperative Haemostasis provides the strongest guidance here, explicitly stating aspirin "should be resumed as early as possible after the invasive procedure, if possible same day, according to the risk of postoperative bleeding" 1. This represents strong consensus among European experts.

Patients with Coronary Stents (Critical Timing)

For patients with coronary stents who required aspirin discontinuation:

• Continue aspirin perioperatively whenever possible to prevent stent thrombosis 1, 4, 5, 4
• If discontinued, restart immediately postoperatively when hemostasis permits 4, 5, 4
• Within 5 days maximum if both antiplatelet agents were stopped 4

The 2014 ACC/AHA perioperative guidelines emphasize that "in patients with stents undergoing surgery that requires discontinuation of P2Y12 inhibitors, continue aspirin and restart the P2Y12 platelet receptor-inhibitor as soon as possible after surgery" 5. The cardiac transplantation scientific statement notes that when thienopyridines must be stopped, "aspirin should be continued if at all possible and the thienopyridine restarted as soon as possible" 4.

Critical caveat: The median time to stent thrombosis is only 7 days when both aspirin and P2Y12 inhibitors are stopped, versus 122 days when aspirin is maintained 4. This underscores the life-threatening risk of delayed aspirin resumption in stented patients.

Practical Algorithm for Resumption

Step 1: Assess Surgical Hemostasis

• Adequate hemostasis achieved → Resume aspirin same day (evening of surgery)
• Ongoing bleeding concerns → Delay 24-48 hours
• High-risk bleeding procedure → Consider 48-72 hour delay

Step 2: Consider Patient-Specific Thrombotic Risk

• High thrombotic risk (recent stent <12 months, recent MI, multiple stents): Resume within 24 hours unless prohibitive bleeding
• Moderate risk (stable CAD, prior stroke): Resume within 24-48 hours
• Low risk (primary prevention only): Resume within 24-72 hours based on bleeding assessment

Step 3: Dose Considerations

• Resume at usual maintenance dose (typically 81 mg daily) 6, 3
• No loading dose required for aspirin resumption
• The 2023 AHA/ACC performance measures confirm that 81 mg daily meets quality standards post-CABG 6

Common Pitfalls to Avoid

Do not delay aspirin resumption beyond 5 days in high-risk patients. The 2012 AHA/ACC transplantation statement explicitly warns that when both antiplatelet agents must be stopped, they "should be restarted as soon as possible after the surgery, certainly within 5 days of the procedure" 4.

Do not confuse aspirin timing with P2Y12 inhibitor timing. While P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) should be resumed within 24-72 hours 1, aspirin can often be resumed even earlier—same day in many cases.

Do not automatically delay resumption in all high-bleeding-risk surgeries. The 2022 CHEST guidelines note that even after high-bleed-risk procedures, anticoagulants can be resumed at 48-72 hours 2, 3. Aspirin, with its lower bleeding risk profile, can often be resumed earlier.

Special Considerations

Neuraxial anesthesia/epidural catheters: Epidural catheter use "should not compromise the postoperative resumption of APAs, especially P2Y12 inhibitors" 1. This implies aspirin resumption should proceed on schedule even with epidural catheters in place, though coordination with anesthesia is prudent.

Dual antiplatelet therapy (DAPT): When both aspirin and a P2Y12 inhibitor were held, prioritize resuming both agents expeditiously. The French guidelines state P2Y12 inhibitors should resume "within 24 to 72 hours after surgery, given the increased thrombotic risk" 1.

Inadequate hemostasis scenarios: If surgical site hemostasis is inadequate, anticipated need for re-intervention exists, or patient cannot take oral medications, delay is justified 3. However, reassess daily and resume as soon as these barriers resolve.

The evidence consistently supports early aspirin resumption to minimize thrombotic complications, with timing individualized based on bleeding risk assessment rather than arbitrary fixed intervals. The default should be same-day or next-day resumption unless specific bleeding concerns dictate otherwise.